Replies to post #1777 on Ampio Pharmaceuticals Inc (AMPE)

[joseytheoutlawwales]

Added from .22 to .24, another 24500 shares.

I see this drop as way oversold. Granted, we need a new ceo, but the compound and science are still strong. We need more info on why the fDa has this position on the trial.

Having to repeat another puts us too far back, and likely in need of further dilution to fund the trial. Hopefully we can climb back to .50s before that dilution hits.

But I believe in what Ampion can do, so I remain a Bull.